Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts

Free Radical Biology and Medicine

Volumn 43, Issue 2, 2007, Pages 253-264

  Dooley, Audrey ^a   Gao, Beirong ^a   Shi Wen, Xu ^a   Abraham, David J ^a   Black, Carol M ^a   Jacobs, Michael ^a   Bruckdorfer, K Richard ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Ascorbic acid; Fibroblast; Free radicals; Nitric oxide; Peroxynitrite; Systemic sclerosis; Type I collagen

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; COLLAGEN TYPE 1; CYCLIC GMP; FREE RADICAL; INTERSTITIAL COLLAGENASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;

ARTICLE; CELL LINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DERMIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REACTION ANALYSIS; SCLERODERMA; UPREGULATION;

ASCORBIC ACID; CELL SURVIVAL; COLLAGEN TYPE I; FIBROBLASTS; HUMANS; KINETICS; NITRIC OXIDE; NITROPRUSSIDE; PEROXYNITROUS ACID; POTASSIUM CYANIDE; SCLERODERMA, SYSTEMIC; SKIN;

EID: 34250810263     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.04.017     Document Type: Article

References (60)

1. Cals-Grierson M.M., and Ormerod A.D. Nitric oxide function in the skin. Nitric Oxide 10 (2004) 179-193
2. Clancy R.M., Amin A.R., and Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41 (1998) 1141-1151
3. Matucci C.M., and Kahaleh M.B. Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41 (2002) 843-847
4. Chu A.J., and Prasad J.K. Up-regulation by human recombinant transforming growth factor beta-1 of collagen production in cultured dermal fibroblasts is mediated by the inhibition of nitric oxide signaling. J. Am. Coll. Surg. 188 (1999) 271-280
5. Kim N.N., Villegas S., Summerour S.R., and Villarreal F.J. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J. Mol. Cell. Cardiol. 31 (1999) 457-466
6. Kolpakov V., Gordon D., and Kulik T.J. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76 (1995) 305-309
7. Myers P.R., and Tanner M.A. Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 717-722
8. Cao M., Westerhausen-Larson A., Niyibizi C., Kavalkovich K., Georgescu H.I., Rizzo C.F., Hebda P.A., Stefanovic-Racic M., and Evans C.H. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem. J. 324 Pt. 1 (1997) 305-310
9. Craven P.A., Studer R.K., Felder J., Phillips S., and DeRubertis F.R. Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes 46 (1997) 671-681
10. Trachtman H., Futterweit S., and Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 207 (1995) 120-125
11. Owens M.W., Milligan S.A., and Grisham M.B. Inhibition of pleural mesothelial cell collagen synthesis by nitric oxide. Free Radic. Biol. Med. 21 (1996) 601-607
12. Genovese T., Cuzzocrea S., di Paola R., Failla M., Mazzon E., Sortino M.A., Frasca G., Gili E., Crimi N., Caputi A.P., and Vancheri C. Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir. Res. 6 (2005) 58
13. Giri S.N., Biring I., Nguyen T., Wang Q., and Hyde D.M. Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. Nitric Oxide 7 (2002) 109-118
14. Ferrini M.G., Vernet D., Magee T.R., Shahed A., Qian A., Rajfer J., and Gonzalez-Cadavid N.F. Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 6 (2002) 283-294
15. Thornton F.J., Schaffer M.R., Witte M.B., Moldawer L.L., MacKay S.L., Abouhamze A., Tannahill C.L., and Barbul A. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem. Biophys. Res. Commun. 246 (1998) 654-659
16. Trachtman H., Futterweit S., Garg P., Reddy K., and Singhal P.C. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 218 (1996) 704-708
17. Zaragoza C., Balbin M., Lopez-Otin C., and Lamas S. Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium. Kidney Int. 61 (2002) 804-808
18. Akool e., Doller A., Muller R., Gutwein P., Xin C., Huwiler A., Pfeilschifter J., and Eberhardt W. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway. J. Biol. Chem. 280 (2005) 39403-39416
19. Saura M., Zaragoza C., Herranz B., Griera M., Diez-Marques L., Rodriguez-Puyol D., and Rodriguez-Puyol M. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells. Circ. Res. 97 (2005) 1115-1123
20. Valente E.G., Vernet D., Ferrini M.G., Qian A., Rajfer J., and Gonzalez-Cadavid N.F. L-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 9 (2003) 229-244
21. Beltran B., Orsi A., Clementi E., and Moncada S. Oxidative stress and S-nitrosylation of proteins in cells. Br. J. Pharmacol. 129 (2000) 953-960
22. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol 271 (1996) C1424-C1437
23. Black C.M., and Denton C.P. Scleroderma and related disorders in adults and children. In: Maddison P.J., Isenberg D.A., Woo P., and Glass D.N. (Eds). Oxford textbook of rheumatology. second edition (1998), Oxford Univ. Press, New York 1217-1247
24. Leask A., Denton C.P., and Abraham D.J. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J. Invest. Dermatol. 122 (2004) 1-6
25. Cotton S.A., Herrick A.L., Jayson M.I., and Freemont A.J. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J. Pathol. 189 (1999) 273-278
26. Yamamoto T., Katayama I., and Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J. Rheumatol. 25 (1998) 314-317
27. Dooley A., Gao B., Bradley N., Abraham D.J., Black C.M., Jacobs M., and Bruckdorfer K.R. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford) 45 (2006) 676-684
28. Sambo P., Baroni S.S., Luchetti M., Paroncini P., Dusi S., Orlandini G., and Gabrielli A. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 44 (2001) 2653-2664
29. Sambo P., Jannino L., Candela M., Salvi A., Donini M., Dusi S., Luchetti M.M., and Gabrielli A. Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion. J. Invest. Dermatol. 112 (1999) 78-84
30. Bruckdorfer K.R., Hillary J.B., Bunce T., Vancheeswaran R., and Black C.M. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 38 (1995) 1060-1067
31. Denton C.P., Bunce T.D., Darado M.B., Roberts Z., Wilson H., Howell K., Bruckdorfer K.R., and Black C.M. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. Rheumatology (Oxford) 38 (1999) 309-315
32. Naseem K.M., and Bruckdorfer K.R. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem. J. 310 Pt 1 (1995) 149-153
33. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 23 (1980) 581-590
34. Abraham D., Lupoli S., McWhirter A., Plater-Zyberk C., Piela T.H., Korn J.H., Olsen I., and Black C. Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheum. 34 (1991) 1164-1172
35. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
36. Leon O., and Panos C. Effect of streptococcal lipoteichoic acid on prolyl hydroxylase activity as related to collagen formation in mouse fibroblast monolayers. Infect. Immun. 50 (1985) 745-752
37. Peterkofsky B., and DiBlasio R. Modification of the tritium-release assays for prolyl and lysyl hydroxylases using Dowex-50 columns. Anal. Biochem. 66 (1975) 279-286
38. Trupin J.S., Russell J.D., and Russell S.B. Assay of prolyl hydroxylase in cultured fibroblast monolayers. Anal. Biochem. 121 (1982) 219-223
39. Keefer L.K., Nims R.W., Davies K.M., and Wink D.A. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268 (1996) 281-293
40. Kivirikko K.I., Myllyla R., and Pihlajaniemi T. Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J. 3 (1989) 1609-1617
41. Pryor W.A., and Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268 (1995) L699-L722
42. Chakravortty D., and Kumar K.S. Induction of cell proliferation and collagen synthesis in human small intestinal lamina propria fibroblasts by lipopolysaccharide: possible involvement of nitric oxide. Biochem. Biophys. Res. Commun. 240 (1997) 458-463
43. Witte M.B., Thornton F.J., Efron D.T., and Barbul A. Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 4 (2000) 572-582
44. Curran R.D., Ferrari F.K., Kispert P.H., Stadler J., Stuehr D.J., Simmons R.L., and Billiar T.R. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5 (1991) 2085-2092
45. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochem. Biophys. Res. Commun. 171 (1990) 474-479
46. Davidson J.M., LuValle P.A., Zoia O., Quaglino Jr. D., and Giro M. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J. Biol. Chem. 272 (1997) 345-352
47. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic. Res. 25 (1996) 439-454
48. Heller R., Munscher-Paulig F., Grabner R., and Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J. Biol. Chem. 274 (1999) 8254-8260
49. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic. Biol. Med. 28 (2000) 1421-1429
50. Herrick A.L., Rieley F., Schofield D., Hollis S., Braganza J.M., and Jayson M.I. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J. Rheumatol. 21 (1994) 1477-1483
51. Murad S., Grove D., Lindberg K.A., Reynolds G., Sivarajah A., and Pinnell S.R. Regulation of collagen synthesis by ascorbic acid. Proc. Natl. Acad. Sci. USA 78 (1981) 2879-2882
52. Kawaguchi Y., Kitani A., Hara M., Harigai M., Hirose T., Suzuki K., Kawakami M., Hidaka T., Ishizuka T., and Kawagoe M. Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis. J. Rheumatol. 19 (1992) 1195-1201
53. Kawaguchi Y., Harigai M., Kitani A., Suzuki K., Kawakami M., Ishizuka T., Hidaka T., Hara M., Kawagoe M., and Nakamura H. Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis. J. Rheumatol. 19 (1992) 1710-1715
54. Peltonen L., Palotie A., Myllyla R., Krieg T., and Oikarinen A. Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts. J. Invest. Dermatol. 84 (1985) 14-18
55. Paik D.C., Dillon J., Galicia E., and Tilson M.D. The nitrite/collagen reaction: non-enzymatic nitration as a model system for age-related damage. Connect. Tissue Res. 42 (2001) 111-122
56. Siwik D.A., Pagano P.J., and Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280 (2001) C53-C60
57. Szabo C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic. Biol. Med. 21 (1996) 855-869
58. Casciola-Rosen L., Wigley F., and Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J. Exp. Med. 185 (1997) 71-79
59. Herrick A.L., Illingworth K.J., Hollis S., Gomez-Zumaquero J.M., and Tinahones F.J. Antibodies against oxidized low-density lipoproteins in systemic sclerosis. Rheumatology (Oxford) 40 (2001) 401-405
60. Stein C.M., Tanner S.B., Awad J.A., Roberts L.J., and Morrow J.D. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 39 (1996) 1146-1150